ZOWALL CONSULTING HEALTH ECONOMICS & OUTCOMES RESEARCH
|
|
 |
Hanna
Zowall has been conducting cost evaluation studies and specializing
in economic studies for formulary submissions since 1989.
Prof. Hanna Zowall, McGill University |
 |
| Hanna Zowall (publications) |
 |
| Hanna
Zowall has been conducting cost evaluation studies and specializing
in economic studies for formulary submissions since 1989. For
over 10 years, Hanna Zowall was a Director of Economic Evaluations
in the Centre for the Analysis of Cost-Effective Care, Division
of Clinical Epidemiology at The Montreal General Hospital, McGill
University, Montreal, Canada.
She is a co-author of medical studies published in Circulation, Archives of Internal Medicine, JAMA, CMAJ and Diabetes Care. She has served as a member of the University-Industry Committee, Canadian Institutes of Health Research (CIHR), a major funding body in Canada. In 2000, together with her colleagues from The Montreal General Hospital she was a recipient of Prix IMS Health Canada for the best cost-effectiveness study. Her area of expertise includes developing databases of standard health care costs in Canada, the United Kingdom, the United States, and other countries, setting up the appropriate types of economic evaluation such as cost-effectiveness, cost-benefit, cost-utility and cost-comparison, designing prospective health economics studies by collecting, analyzing and evaluating clinical, quality of life and economic outcomes. Hanna Zowall has co-authored economic evaluation studies in the areas of cardiovascular disease, prostate cancer, diabetes and HIV. She has developed Canadian, American and British cost databases for cardiovascular diseases, hyperlipidemia, diabetes, HIV, prostate cancer, and other diseases. She is currently teaching health economics and the financial aspect of health care at Concordia University and at McGill University in Montreal, Canada. |
| | | About us | | | Services | | | Contact us |